GROWTH EQUITY OPPORTUNITIES FUND V, LLC - MEI PHARMA, INC. -- SCHEDULE 13D

Company

Lite Strategy, Inc.

Filed

May 23, 2018

Accession Number

0001072613-18-000354

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →